Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Carruthers R Michael
Chief Financial Officer at Edgewise Therapeutics. Filing since 2 May 2023.
CIK 0001644467
Company
Date
Role
Action
Shares
Amount
Of holding
EWTX
Edgewise Therapeutics, Inc.
12 Aug 2025
Chief Financial Officer
Sold at will
1,428
$19.12K
1.6%
EWTX
Edgewise Therapeutics, Inc.
2 May 2025
Chief Financial Officer
Sold at will
1,314
$21.62K
1.6%
EWTX
Edgewise Therapeutics, Inc.
20 Sep 2024
Chief Financial Officer
Sold at will
125,092
$3.57M
94.8%
EWTX
Edgewise Therapeutics, Inc.
2 May 2024
Chief Financial Officer
Sold at will
2,157
$40.79K
5.8%
EWTX
Edgewise Therapeutics, Inc.
23 Jan 2024
Chief Financial Officer
Sold on a plan
90,000
$1.42M
75.6%
EWTX
Edgewise Therapeutics, Inc.
2 May 2023
Chief Financial Officer
Sold at will
1,336
$11.90K
7.7%
6 decisions on file.
